Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 6 studies | 21% ± 6% | |
epithelial cell | 6 studies | 27% ± 12% | |
ciliated cell | 5 studies | 28% ± 8% | |
endothelial cell | 5 studies | 22% ± 5% | |
plasma cell | 4 studies | 27% ± 10% | |
goblet cell | 4 studies | 20% ± 2% | |
smooth muscle cell | 3 studies | 20% ± 1% | |
dendritic cell | 3 studies | 24% ± 4% | |
basal cell | 3 studies | 23% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2862.78 | 1445 / 1445 | 100% | 60.37 | 183 / 183 |
kidney | 100% | 2632.22 | 89 / 89 | 100% | 101.91 | 901 / 901 |
ovary | 100% | 2393.03 | 180 / 180 | 100% | 102.39 | 430 / 430 |
pancreas | 100% | 1765.72 | 328 / 328 | 100% | 141.74 | 178 / 178 |
prostate | 100% | 4431.29 | 245 / 245 | 100% | 186.33 | 502 / 502 |
thymus | 100% | 2890.14 | 653 / 653 | 100% | 129.47 | 605 / 605 |
brain | 100% | 2974.34 | 2640 / 2642 | 100% | 130.56 | 705 / 705 |
breast | 100% | 2620.97 | 459 / 459 | 100% | 139.55 | 1117 / 1118 |
uterus | 100% | 3258.46 | 170 / 170 | 100% | 100.16 | 458 / 459 |
skin | 100% | 2145.48 | 1808 / 1809 | 100% | 90.49 | 471 / 472 |
stomach | 100% | 2710.86 | 359 / 359 | 100% | 80.42 | 285 / 286 |
intestine | 100% | 3116.07 | 966 / 966 | 100% | 92.05 | 525 / 527 |
lung | 100% | 2525.16 | 576 / 578 | 100% | 101.38 | 1154 / 1155 |
adrenal gland | 100% | 4383.71 | 258 / 258 | 100% | 115.79 | 229 / 230 |
bladder | 100% | 3067.90 | 21 / 21 | 99% | 94.05 | 499 / 504 |
liver | 99% | 1534.62 | 224 / 226 | 99% | 63.65 | 401 / 406 |
adipose | 100% | 2470.46 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4000.69 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 82.87 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 87.34 | 29 / 29 |
spleen | 100% | 2156.44 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 75.50 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 46.27 | 1 / 1 |
heart | 99% | 1727.54 | 851 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 1234.00 | 788 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 89% | 1188.91 | 823 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902236 | Biological process | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0090026 | Biological process | positive regulation of monocyte chemotaxis |
GO_0006935 | Biological process | chemotaxis |
GO_0030968 | Biological process | endoplasmic reticulum unfolded protein response |
GO_0140467 | Biological process | integrated stress response signaling |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000139 | Cellular component | Golgi membrane |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0001221 | Molecular function | transcription coregulator binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CREB3 |
Protein name | Cyclic AMP-responsive element-binding protein 3 (CREB-3) (cAMP-responsive element-binding protein 3) (Leucine zipper protein) (Luman) (Transcription factor LZIP-alpha) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3 (N-terminal Luman) (Transcriptionally active form)] |
Synonyms | LZIP |
Description | FUNCTION: Endoplasmic reticulum (ER)-bound sequence-specific transcription factor that directly binds DNA and activates transcription . Plays a role in the unfolded protein response (UPR), promoting cell survival versus ER stress-induced apoptotic cell death . Also involved in cell proliferation, migration and differentiation, tumor suppression and inflammatory gene expression. Acts as a positive regulator of LKN-1/CCL15-induced chemotaxis signaling of leukocyte cell migration . Associates with chromatin to the HERPUD1 promoter . Also induces transcriptional activation of chemokine receptors . .; FUNCTION: (Microbial infection) Plays a role in human immunodeficiency virus type 1 (HIV-1) virus protein expression. .; FUNCTION: [Isoform 1]: (Microbial infection) May play a role as a cellular tumor suppressor that is targeted by the hepatitis C virus (HCV) core protein. .; FUNCTION: [Isoform 1]: (Microbial infection) Plays a role in herpes simplex virus-1 (HSV-1) latent infection and reactivation from latency. Represses the VP16-mediated transactivation of immediate early genes of the HSV-1 virus by sequestering host cell factor-1 HCFC1 in the ER membrane of sensory neurons, thereby preventing the initiation of the replicative cascade leading to latent infection. .; FUNCTION: [Isoform 2]: Functions as a negative transcriptional regulator in ligand-induced transcriptional activation of the glucocorticoid receptor NR3C1 by recruiting and activating histone deacetylases (HDAC1, HDAC2 and HDAC6). Also decreases the acetylation level of histone H4. Does not promote the chemotactic activity of leukocyte cells. .; FUNCTION: [Processed cyclic AMP-responsive element-binding protein 3]: This is the transcriptionally active form that translocates to the nucleus and activates unfolded protein response (UPR) target genes during endoplasmic reticulum (ER) stress response. Binds the cAMP response element (CRE) (consensus: 5'-GTGACGT[AG][AG]-3') and C/EBP sequences present in many promoters to activate transcription of the genes. Binds to the unfolded protein response element (UPRE) consensus sequences sites. Binds DNA to the 5'-CCAC[GA]-3'half of ERSE II (5'-ATTGG-N-CCACG-3'). .; FUNCTION: [Processed cyclic AMP-responsive element-binding protein 3]: (Microbial infection) Activates transcription of genes required for reactivation of the latent HSV-1 virus. It's transcriptional activity is inhibited by CREBZF in a HCFC1-dependent manner, by the viral transactivator protein VP16. Binds DNA to the cAMP response element (CRE) (consensus: 5'-GTGACGT[AG][AG]-3') and C/EBP sequences present in many viral promoters. .; FUNCTION: [Processed cyclic AMP-responsive element-binding protein 3]: (Microbial infection) It's transcriptional activity is inhibited by CREBZF in a HCFC1-dependent manner, by the viral transactivator HCV core protein. . |
Accessions | ENST00000353704.3 [O43889-2] O43889 |